Citations (67)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Sevil Fisekci Oktar, Ibrahim Guney, Sayeste Akkan Eren, Levent Oktar, Kenan Kosar, Zafer Buyukterzi, Ender Alkan, Zeynep Biyik & Said Sami Erdem. (2019) Serum endocan levels, carotid intima-media thickness and microalbuminuria in patients with newly diagnosed hypertension. Clinical and Experimental Hypertension 41:8, pages 787-794.
Read now
Read now
Xinxing Zhu, Duchu Chen, Yanli Liu, Jinjin Yu, Liang Qiao, Shuibin Lin, Demeng Chen, Genshen Zhong, Xifeng Lu, Yize Wang, Jieqi Wen, Xinqi Zhong & Yizhou Jiang. (2019) Long Noncoding RNA HOXA-AS3 Integrates NF-κB Signaling To Regulate Endothelium Inflammation. Molecular and Cellular Biology 39:19.
Read now
Read now
Khalil Ali Ahmad, Dai Yuan Yuan, Waqas Nawaz, Hong Ze, Chen Xue Zhuo, Bashar Talal, Abdoh Taleb, Enos Mais & Ding Qilong. (2017) Antioxidant therapy for management of oxidative stress induced hypertension. Free Radical Research 51:4, pages 428-438.
Read now
Read now
Mehmet Ali Cikrikcioglu, Zeynep Erturk, Elif Kilic, Kenan Celik, Iskender Ekinci, Ayse Irem Yasin Cetin, Tuba Ozkan, Guven Cetin, Shute Ailia Dae, Rumeyza Kazancioglu & Reha Erkoc. (2016) Endocan and albuminuria in type 2 diabetes mellitus. Renal Failure 38:10, pages 1647-1653.
Read now
Read now
Kenan Celik, Mehmet A Cikrikcioglu, Gulistan Halac, Elif Kilic, Siddika Ayhan, Nihal Ozaras, Kemal Yildiz, Rabia S Yildiz, Mehmet Zorlu, Cumali Karatoprak, Mustafa Cakirca & Muharrem Kiskac. (2015) Serum endocan levels in women with restless legs syndrome. Neuropsychiatric Disease and Treatment 11, pages 2919-2925.
Read now
Read now
Articles from other publishers (62)
Shin Takasawa, Mai Makino, Akiyo Yamauchi, Sumiyo Sakuramoto‐Tsuchida, Rina Hirota, Ryusei Fujii, Keito Asai, Yoshinori Takeda, Tomoko Uchiyama, Ryogo Shobatake & Hiroyo Ota. (2023)
Intermittent hypoxia increased the expression of
ESM1
and
ICAM‐1
in vascular endothelial cells via the downregulation of
microRNA
‐181a1
. Journal of Cellular and Molecular Medicine.
Crossref
Crossref
Amir Hossein Behnoush, Amirmohammad Khalaji, Pegah Bahiraie, Parsa Alehossein, Parnian Shobeiri, Maral Peisepar & Alessandro Cannavo. (2023) Endocan as a marker of endothelial dysfunction in hypertension: a systematic review and meta-analysis. Hypertension Research.
Crossref
Crossref
Ebru Şahan, Eray Metin Güler, Aise Tangılntız & İsmet Kırpınar. (2023) Endocan: A novel biomarker of endothelial dysfunction in depression?. Journal of Psychiatric Research.
Crossref
Crossref
Aleksandra Klisic & Dimitrios Patoulias. (2023) The Role of Endocan in Cardiometabolic Disorders. Metabolites 13:5, pages 640.
Crossref
Crossref
Serap Ozer Yaman, Fulya Balaban Yucesan, Cihan Orem, Birgul Vanizor Kural & Asım Orem. (2023) Elevated Circulating Endocan Levels Are Associated with Increased Levels of Endothelial and Inflammation Factors in Postprandial Lipemia. Journal of Clinical Medicine 12:4, pages 1267.
Crossref
Crossref
Serkan Yazan, Hüseyin Karakurt & Hamdi Püşüroğlu. (2023) Relationship Between Obstructive Sleep Apnea Severity and Serum Endocan Levels in Patients With Hypertension. Texas Heart Institute Journal 50:1.
Crossref
Crossref
Gaurav Kumar, Sanjay Kumar Dey & Suman Kundu. 2023. Nitric Oxide: From Research to Therapeutics. Nitric Oxide: From Research to Therapeutics
41
66
.
Dmitry V. Shcheblykin, Anton A. Bolgov, Mikhail V. Pokrovskii, Julia V. Stepenko, Julia M. Tsuverkalova, Olesya V. Shcheblykina, Polina A. Golubinskaya & Liliya V. Korokina. (2022) Endothelial dysfunction: developmental mechanisms and therapeutic strategies. Research Results in Pharmacology 8:4, pages 115-139.
Crossref
Crossref
Sevket Balta. (2022) Atherosclerosis and Non-Alcoholic Fatty Liver Disease. Angiology 73:8, pages 701-711.
Crossref
Crossref
Marta Reina-Couto, Carolina Silva-Pereira, Patrícia Pereira-Terra, Janete Quelhas-Santos, João Bessa, Paula Serrão, Joana Afonso, Sandra Martins, Cláudia Camila Dias, Manuela Morato, João T Guimarães, Roberto Roncon-Albuquerque, José-Artur Paiva, António Albino-Teixeira & Teresa Sousa. (2022) Endothelitis profile in acute heart failure and cardiogenic shock patients: Endocan as a potential novel biomarker and putative therapeutic target. Frontiers in Physiology 13.
Crossref
Crossref
Handan Alay & Esra Laloglu. (2022) Can Endocan Be a Novel Marker in the Diagnosis of Brucellosis?. Vector-Borne and Zoonotic Diseases 22:4, pages 232-237.
Crossref
Crossref
Pasquale Ambrosino, Ilenia Lorenza Calcaterra, Marco Mosella, Roberto Formisano, Silvestro Ennio D’Anna, Tiziana Bachetti, Giuseppina Marcuccio, Brurya Galloway, Francesco Paolo Mancini, Antimo Papa, Andrea Motta, Matteo Nicola Dario Di Minno & Mauro Maniscalco. (2022) Endothelial Dysfunction in COVID-19: A Unifying Mechanism and a Potential Therapeutic Target. Biomedicines 10:4, pages 812.
Crossref
Crossref
Elisabeth Samouilidou, Virginia Athanasiadou & Eirini Grapsa. (2022) Prognostic and Diagnostic Value of Endocan in Kidney Diseases. International Journal of Nephrology 2022, pages 1-13.
Crossref
Crossref
Ahmet Omma, Berkan Armaǧan, Serdar Can Güven, Sevinç Can Sandıkçı, Seda Çolak, Çiǧdem Yücel, Orhan Küçükşahin & Abdulsamet Erden. (2021) Endocan: A Novel Marker for Colchicine Resistance in Familial Mediterranean Fever Patients?. Frontiers in Pediatrics 9.
Crossref
Crossref
Sevket Balta, Ilknur Balta & Dimitri P. Mikhailidis. (2021) Endocan: a new marker of endothelial function. Current Opinion in Cardiology 36:4, pages 462-468.
Crossref
Crossref
Ertuğrul Emre Güntürk, İnayet Güntürk, Ayşe Nur Topuz, Hasan Akkaya & Mustafa Topuz. (2020) Serum interleukin-18 levels are associated with non-dipping pattern in newly diagnosed hypertensive patients. Blood Pressure Monitoring 26:2, pages 87-92.
Crossref
Crossref
Şevket Balta. (2020) COVID-19 and Endocan Levels. Angiology 72:3, pages 209-209.
Crossref
Crossref
Mahmut APAYDIN, Taner DEMİRCİ & Erman ÇAKAL. (2021) POLİKİSTİK OVER SENDROMUNDA (PKOS) ENDOTELYAL DİSFONKSİYONUN ERKEN SERUM BELİRTECİ: ENDOCAN. Sakarya Medical Journal.
Crossref
Crossref
Marwa Yahia Mahgoub, Ali Ibrahim Fouda, Ahmed Yousef Elshambaky, Walaa Bayoumie Elgazzar & Sara Abdellatif Shalaby. (2020) Validity of endocan as a biomarker in systemic sclerosis: relation to pathogenesis and disease activity. Egyptian Rheumatology and Rehabilitation 47:1.
Crossref
Crossref
Gaurav Kumar, Sanjay Kumar Dey & Suman Kundu. (2020) Functional implications of vascular endothelium in regulation of endothelial nitric oxide synthesis to control blood pressure and cardiac functions. Life Sciences 259, pages 118377.
Crossref
Crossref
João Bessa, António Albino-Teixeira, Marta Reina-Couto & Teresa Sousa. (2020) Endocan: A novel biomarker for risk stratification, prognosis and therapeutic monitoring in human cardiovascular and renal diseases. Clinica Chimica Acta 509, pages 310-335.
Crossref
Crossref
Ecem Kaya-Sezginer & Serap Gur. (2020) The Inflammation Network in the Pathogenesis of Erectile Dysfunction: Attractive Potential Therapeutic Targets. Current Pharmaceutical Design 26:32, pages 3955-3972.
Crossref
Crossref
Laura Piqueras & Maria-Jesus Sanz. (2020) Angiotensin II and leukocyte trafficking: New insights for an old vascular mediator. Role of redox-signaling pathways. Free Radical Biology and Medicine 157, pages 38-54.
Crossref
Crossref
Charilaos Triantafyllou, Maria Nikolaou, Ignatios Ikonomidis, Giorgos Bamias & Ioannis Papaconstantinou. (2019) Endothelial and Cardiac Dysfunction in Inflammatory Bowel Diseases: Does Treatment Modify the Inflammatory Load on Arterial and Cardiac Structure and Function?. Current Vascular Pharmacology 18:1, pages 27-37.
Crossref
Crossref
Haili Sun, Fang Fang, Kun Li, Huina Zhang, Ming Zhang, Lichuan Zhang, Juan Li, Yanwen Qin & Yongxiang Wei. (2019) Circulating ESM-1 levels are correlated with the presence of coronary artery disease in patients with obstructive sleep apnea. Respiratory Research 20:1.
Crossref
Crossref
Sevket Balta & Dimitri P. Mikhailidis. (2019) Endocan and Erectile Dysfunction. American Journal of Men's Health 13:6, pages 155798831989388.
Crossref
Crossref
Mojtaba Ziaee, Sina Mashayekhi, Samad Ghaffari, Javad Mahmoudi, Parvin Sarbakhsh & Alireza Garjani. (2018) Predictive Value of Endocan Based on TIMI Risk Score on Major Adverse Cardiovascular Events After Acute Coronary Syndrome. Angiology 70:10, pages 952-959.
Crossref
Crossref
Miroslav Radenković, Marko Stojanović & Milica Prostran. (2019) Calcium Channel Blockers in Restoration of Endothelial Function: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Current Medicinal Chemistry 26:29, pages 5579-5595.
Crossref
Crossref
Jinjin Yu, Hong Ming, Henry You Li, Bin Yu, Maoping Chu, Haibo Zhu & Xinxing Zhu. (2019) IMM-H007, a novel small molecule inhibitor for atherosclerosis, represses endothelium inflammation by regulating the activity of NF-κB and JNK/AP1 signaling. Toxicology and Applied Pharmacology 381, pages 114732.
Crossref
Crossref
Mustafa Çelik, Erdoğan Sökmen, Serkan Sivri, Cahit Uçar, Rukiye Nar & Murat Erer. (2019) The Relationship Between Serum Endocan Level and Aortic Elastic Properties in Patients With Newly Diagnosed Essential Hypertension. Angiology 70:7, pages 662-668.
Crossref
Crossref
Isabella Viana Gomes Silva, Roberta Carvalho de Figueiredo & Danyelle Romana Alves Rios. (2019) Effect of Different Classes of Antihypertensive Drugs on Endothelial Function and Inflammation. International Journal of Molecular Sciences 20:14, pages 3458.
Crossref
Crossref
Annabella Braschi. (2019) Potential Protective Role of Blood Pressure-Lowering Drugs on the Balance between Hemostasis and Fibrinolysis in Hypertensive Patients at Rest and During Exercise. American Journal of Cardiovascular Drugs 19:2, pages 133-171.
Crossref
Crossref
Yu Ho Lee, Se-Yun Kim, Haena Moon, Jung-Woo Seo, Dong-Jin Kim, Seon Hwa Park, Yang-Gyun Kim, Ju-Young Moon, Jin Sug Kim, Kyung-Hwan Jeong, Sung-Jig Lim, Chan-Duck Kim, Jae Berm Park, Byung Ha Chung, Yeong Hoon Kim, Jaeseok Yang, Hyung-In Yang, Kyoung Soo Kim & Sang-Ho Lee. (2019) Endocan as a marker of microvascular inflammation in kidney transplant recipients. Scientific Reports 9:1.
Crossref
Crossref
R.P. Ravindra, S. Arunkumar, R.R. Puniyani, K. Padgaonkar, Ramalingam Vadivelu, Rajeev Sharma, Gopi Panicker & Yash Lokhandwala. (2019) Amlodipine alters hemorheological parameters: Increased efficacy at the cost of edema?. Indian Heart Journal 71:1, pages 32-38.
Crossref
Crossref
Abdel Aal M. Elkamshoushi, Eman M. Hassan, Amr M. El Abd, Seham Z. Hassan & Amer A. Maher. (2018) Serum endocan as a predictive biomarker of cardiovascular risk in erectile dysfunction patients. Andrologia 50:10, pages e13113.
Crossref
Crossref
Tianming Zhao, Yao Kecheng, Xuelei Zhao, Xuehua Hu, Jing Zhu, Yingnan Wang & Jixiang Ni. (2018) The higher serum endocan levels may be a risk factor for the onset of cardiovascular disease. Medicine 97:49, pages e13407.
Crossref
Crossref
Adrien Bouglé, Pierre-Antoine Allain, Séverine Favard, Nora Ait Hamou, Aude Carillion, Pascal Leprince, Benjamin Granger & Julien Amour. (2018) Postoperative serum levels of Endocan are associated with the duration of norepinephrine support after coronary artery bypass surgery. Anaesthesia Critical Care & Pain Medicine 37:6, pages 565-570.
Crossref
Crossref
Gonul Aciksari, Murat Kavas, Adem Atici, Seref Kul, Hayriye Erman, Yusuf Yilmaz, Kenan Demircioglu, Emre Yalcinkaya, Asiye Kanbay & Mustafa Caliskan. (2018) Endocan Levels and Endothelial Dysfunction in Patients With Sarcoidosis. Angiology 69:10, pages 878-883.
Crossref
Crossref
Alexandre Gaudet, Erika Parmentier, Sylvain Dubucquoi, Julien Poissy, Thibault Duburcq, Philippe Lassalle, Nathalie De Freitas Caires & Daniel Mathieu. (2018) Low endocan levels are predictive of Acute Respiratory Distress Syndrome in severe sepsis and septic shock. Journal of Critical Care 47, pages 121-126.
Crossref
Crossref
Ilhan Balamir, Ihsan Ates, Canan Topcuoglu & Turan Turhan. (2017) Association of Endocan, Ischemia-Modified Albumin, and hsCRP Levels With Endothelial Dysfunction in Type 2 Diabetes Mellitus. Angiology 69:7, pages 609-616.
Crossref
Crossref
Dominika Musialowska, Edyta Zbroch, Ewa Koc-Zorawska, Piotr Musialowski & Jolanta Malyszko. (2017) Endocan Concentration in Patients With Primary Hypertension. Angiology 69:6, pages 483-489.
Crossref
Crossref
J. Malyszko, E. Koc-Żórawska & J.S. Malyszko. (2018) Endocan Concentration in Kidney Transplant Recipients. Transplantation Proceedings 50:6, pages 1798-1801.
Crossref
Crossref
Victoria A Serhiyenko & Alexandr A Serhiyenko. (2018) Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment. World Journal of Diabetes 9:1, pages 1-24.
Crossref
Crossref
Yanhong Meng, Ling Zong, Ziteng Zhang, Youdong Han & Yanhui Wang. (2017) Evaluation of changes in left ventricular structure and function in hypertensive patients with coronary artery disease after PCI using real-time three-dimensional echocardiography. Experimental and Therapeutic Medicine.
Crossref
Crossref
Veysel Ozalper, Muammer Kara, Alpaslan Tanoglu, Ibrahim Cetındaglı, Coskun Ozturker, Yusuf Hancerlı, Serdar Hıra, Kemal Kara, Yavuz Beyazıt & Yusuf Yazgan. (2017) Evaluation of endothelial dysfunction in patients with familial Mediterranean fever: the relationship between the levels of asymmetric dimethylarginine and endocan with carotid intima–media thickness and endothelium-dependent vasodilation. Clinical Rheumatology 36:9, pages 2071-2077.
Crossref
Crossref
Satoru Oka, Yoko Obata, Shuntaro Sato, Kenta Torigoe, Miki Sawa, Shinichi Abe, Kumiko Muta, Yuki Ota, Mineaki Kitamura, Satoko Kawasaki, Misaki Hirose, Tadashi Uramatsu, Hiroshi Mukae & Tomoya Nishino. (2017) Serum Endocan as a Predictive Marker for Decreased Urine Volume in Peritoneal Dialysis Patients. Medical Science Monitor 23, pages 1464-1470.
Crossref
Crossref
Chong-Rong Qiu, Qiang Fu, Jian Sui, Qian Zhang, Peng Wei, Yan Wu, Ke Zhu, Yi Lu & Peng Wan. (2016) Analysis of Serum Endothelial Cell-Specific Molecule 1 (Endocan) Level in Type 2 Diabetes Mellitus With Acute ST-Segment Elevation Myocardial Infarction and its Correlation. Angiology 68:1, pages 74-78.
Crossref
Crossref
Rufeng Shi, Kai Liu, Di Shi, Qi Liu & Xiaoping Chen. (2017) Effects of Amlodipine and Valsartan on Blood Pressure Variability and Pulse Wave Velocity in Hypertensive Patients. The American Journal of the Medical Sciences 353:1, pages 6-11.
Crossref
Crossref
Tolga Çimen, Tolga Han Efe, Ahmet Akyel, Hamza Sunman, Engin Algül, Haluk Furkan Şahan, Gönül Erden, Şeyda Özdemir, Emine Figen Alay, Mehmet Doğan & Ekrem Yeter. (2016) Human Endothelial Cell-Specific Molecule-1 (Endocan) and Coronary Artery Disease and Microvascular Angina. Angiology 67:9, pages 846-853.
Crossref
Crossref
Chongrong Qiu, Jian Sui, Qian Zhang, Peng Wei, Peng Wang & Qiang Fu. (2016) Relationship of Endothelial Cell–Specific Molecule 1 Level in Stress Hyperglycemia Patients With Acute ST-Segment Elevation Myocardial Infarction. Angiology 67:9, pages 829-834.
Crossref
Crossref
Yu Ho Lee, Jin Sug Kim, Se-Yun Kim, Yang Gyun Kim, Ju-Young Moon, Kyung-Hwan Jeong, Tae Won Lee, Chun-Gyoo Ihm & Sang-Ho Lee. (2016) Plasma endocan level and prognosis of immunoglobulin A nephropathy. Kidney Research and Clinical Practice 35:3, pages 152-159.
Crossref
Crossref
Paul Bălănescu, Anca Lădaru, Eugenia Bălănescu, Theodor Voiosu, Cristian Băicuş & Gheorghe Andrei Dan. (2016) Endocan, Novel Potential Biomarker for Systemic Sclerosis: Results of a Pilot Study. Journal of Clinical Laboratory Analysis 30:5, pages 368-373.
Crossref
Crossref
Pradeep R. Madhivathanan, Nick Fletcher, David Gaze, Rebekah Thomson, Venkatachalam Chandrasekaran, Nawaf Al-Subaie, Oswaldo Valencia & Vivek Sharma. (2016) Perioperative kinetics of endocan in patients undergoing cardiac surgery with and without cardiopulmonary bypass. Cytokine 83, pages 8-12.
Crossref
Crossref
Sevket Balta & Cengiz Ozturk. (2015) Endocan, Obstructive Sleep Apnea, and Vascular Risk. Angiology 67:4, pages 305-306.
Crossref
Crossref
Eylem Kiral, Ener Cagri Dinleyici, Ayse Bozkurt-Turhan, Ozcan Bor, Yurdanur Akgun & Necat Akdeniz Akgun. (2016) Serum Endocan Levels in Children with Febrile Neutropenia. Hematology Reports 8:1, pages 6110.
Crossref
Crossref
Yucel Arman, Timur Selcuk Akpinar, Murat Kose, Samim Emet, Gulden Yuruyen, Murat Akarsu, Mustafa Ozcan, Ozan Yegit, Ramazan Cakmak, Ozgur Altun, Sengul Aydin, Alpay Alibeyoğlu, Bilal Ugurlu, Tugce Akcan & Tufan Tukek. (2015) Effect of Glycemic Regulation on Endocan Levels in Patients With Diabetes. Angiology 67:3, pages 239-244.
Crossref
Crossref
Tolga ÇimenMurat BilginAhmet AkyelMehmet Ali FelekoğluAli NallbaniŞeyda ÖzdemirGönül ErdenAlpaslan ÖztürkMehmet DoğanEkrem Yeter. (2016) Endocan and Non-Dipping Circadian Pattern in Newly Diagnosed Essential Hypertension. Korean Circulation Journal 46:6, pages 827.
Crossref
Crossref
Livia Victorino de Souza, Vanessa Oliveira, Aline Oliveira Laurindo, DelmaRegına Gomes Huarachı, Paulo Cesar Koch Nogueira, Luciana de Santis Feltran, José Osmar Medina-Pestana & Maria do Carmo Franco. (2016) Serum Endocan Levels Associated with Hypertension and Loss of Renal Function in Pediatric Patients after Two Years from Renal Transplant. International Journal of Nephrology 2016, pages 1-7.
Crossref
Crossref
Dildar Konukoglu & Hafize Uzun. 2017. Hypertension: from basic research to clinical practice. Hypertension: from basic research to clinical practice
511
540
.
Hans-Joachim Anders, Marcus Baumann, Giovanni Tripepi & Francesca Mallamaci. (2015) Immunity in arterial hypertension: associations or causalities?. Nephrology Dialysis Transplantation 30:12, pages 1959-1964.
Crossref
Crossref
Kathryna F. Rodrigues, Nathalia T. Pietrani, Adriana A. Bosco, Lirlândia P. Sousa, Cláudia N. Ferreira, Valeria C. Sandrim & Karina B. Gomes. (2015) Endocan: a new biomarker associated with inflammation in type 2 diabetes mellitus?. Diabetes/Metabolism Research and Reviews 31:5, pages 479-480.
Crossref
Crossref
Sevket Balta, Dimitri P. Mikhailidis, Sait Demirkol, Turgay Celik, Cengiz Ozturk & Atila Iyisoy. (2015) Endocan and Atherosclerosis. Angiology 66:5, pages 490-490.
Crossref
Crossref